Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$948K Hold
33,235
– – 0.43% 24
2026
Q2
$800K Buy
+33,235
New +$869K 0.37% 28
2025
Q4
$828K Buy
+33,235
New +$838K 0.53% 23

Other funds holding PFE

DUNHAM TRUST Co's PFE Position: Q3 2026 in Review

DUNHAM TRUST Co held its Pfizer (PFE) position steady in Q3 2026 at 33,235 shares worth $948K. The position accounts for 0.43% of the portfolio, ranked #24.

DUNHAM TRUST Co first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • DUNHAM TRUST Co held 33,235 shares of Pfizer worth $948K as of Q3 2026.
  • DUNHAM TRUST Co left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.43% of DUNHAM TRUST Co's portfolio in Q3 2026, its #24 holding.
  • DUNHAM TRUST Co first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.